SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-20-177096
Filing Date
2020-06-24
Accepted
2020-06-24 07:46:35
Documents
5

Document Format Files

Seq Description Document Type Size
1 8-K d949145d8k.htm SC TO-C 40949
2 EX-2.1 d949145dex21.htm EX-2.1 712898
3 EX-10.1 d949145dex101.htm EX-10.1 100510
4 EX-10.2 d949145dex102.htm EX-10.2 65700
5 EX-10.3 d949145dex103.htm EX-10.3 46652
  Complete submission text file 0001193125-20-177096.txt   968238
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filed by) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Subject) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-87366 | Film No.: 20983879
SIC: 2834 Pharmaceutical Preparations